Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
Caleb P Skipper(University of Minnesota Medical Center), David R. Boulware(University of Minnesota Medical Center), Nicole Engen(Fairview Health Services), Lauren J MacKenzie(Fairview Health Services), Melanie R. Nicol(University of Minnesota), Matthew F Pullen(Fairview Health Services), Glen Drobot(Fairview Health Services), Matthew P. Cheng(McGill University Health Centre), Sylvain Lother(Fairview Health Services), Emily G. McDonald(McGill University), Ryan Zarychanski(CancerCare Manitoba), Lauren E. Kelly(Fairview Health Services), Alanna A Nascene(Fairview Health Services), Elizabeth C Okafor(Fairview Health Services), Todd C. Lee(McGill University Health Centre), Sarah M Lofgren(Fairview Health Services), Kathy Huppler Hullsiek(University of Minnesota), Darlette Luke(Fairview Health Services), Katelyn A Pastick(Fairview Health Services), Radha Rajasingham(University of Minnesota System), Ilan S. Schwartz(Fairview Health Services), Ananta Bangdiwala(RTI International), Darlisha A Williams(University of Minnesota), Mahsa Abassi(University of Minnesota Medical Center)
Cited by 548
Related Papers
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
|New England Journal of Medicine|2020|1.4k
Estimating Survival in Patients With Lung Cancer and Brain Metastases
|JAMA Oncology|2016|655
Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: A propensity-matched analysis*
|Critical Care Medicine|2010|463
Comparison of Saliva and Nasopharyngeal Swab Nucleic Acid Amplification Testing for Detection of SARS-CoV-2
|JAMA Internal Medicine|2021|327